BioSpace News Archive

Shanghai Henlius Biotech, Inc. (2696.HK) announced that the first interim analysis met the primary study endpoint of the overall survival (OS) of the Phase 3 clinical study (NCT04063163) of its innovative PD-1 inhibitor serplulimab in combination with chemotherapy in previously untreated patients with extensive-stage small cell lung cancer (ES-SCLC).

According to Emergen Research, the global phospholipids market size was USD 3.21 Billion in 2020 and is expected to reach USD 4.81 Billion in 2028 and register a revenue CAGR of 5.3% during the forecast period, 2021-2028.

Physicians and researchers presented the latest scientific developments into pulmonary fibrosis (PF) and interstitial lung disease (ILD), educating more than 1,100 patients, caregivers, health care providers, researchers, and industry professionals at the Pulmonary Fibrosis Foundation’s (PFF) all-virtual sixth biennial healthcare conference, PFF Summit 2021.

BG Medical/ SURGIMESH ® and CQInsights Announce the First Patient Treated in a National Hernia Patient-Centered Outcomes Initiative.

LiquidLung, Inc. is pleased to announce that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for its patent application No. 17/003,775 for claims related to the non-invasive diagnosis of lung cancer.

The OTCQB Venture Market, operated by OTC Markets Group Inc., is designed for developing and entrepreneurial companies in the U.S. and abroad.

Saol Therapeutics announces the approval of LYVISPAH™ (baclofen) oral granules.

Clarus Therapeutics Holdings, Inc. announced that it has closed its previously announced definitive agreement to sell securities in a private placement with a leading healthcare investor.

Journey Medical Corporation announced that management will present at the Benzinga Global Small Cap Conference, which is being held virtually from December 8 – 9, 2021.

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company that develops and manufactures state-of-the-art diagnostics technology used in over 50 countries, announced a partnership with TiiCKER™; a consumer shareholder loyalty platform, to increase its connection to retail investors.